English | Español
Jamie Barrand | Feb 10, 2016

FDA expands label for Bristol-Myers Squibb's Daklinza therapy
Jamie Barrand | Feb 10, 2016

Manufacturers hope to expand labeling on schizophrenia therapy
Jamie Barrand | Feb 10, 2016

Biogen joins Center for Therapeutic Target Validation
Jamie Barrand | Feb 9, 2016

Beta blocker could improve autistic adults' conversational skills, study indicates
Jamie Barrand | Feb 9, 2016

ALS Association to fund new grants
Jamie Barrand | Feb 9, 2016

One World Trade Center to participate in Light It Up Blue autism awareness event
Jamie Barrand | Feb 9, 2016

Third trial of Repatha reveals positive results
Kerry Goff | Feb 9, 2016

AEI fellow anticipates cost increase for health care coverage under Obamacare

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access